In an era where speed, science, and sustainability define the nutraceutical industry, Amit Srivastava, Chief Catalyst and Founder of Nutrify Today, stands at the intersection of innovation and responsibility. With transformative platforms like NutrifyGenie AI, groundbreaking summits like SumFlex, and a rapidly expanding global footprint, Nutrify Today is spearheading a movement to position India as a $100 billion nutraceutical powerhouse. In an in-depth discussion, Srivastava shares how his organization is reshaping the contours of nutrition science and industry practices—grounded in ethics, driven by data, and inclusive by design.
“Time-to-market has always been a fundamental bottleneck in nutraceutical innovation. NutrifyGenie was built to remove that,” says Srivastava, highlighting the platform’s profound impact on reducing development cycles.
NutrifyGenie streamlines complex processes—identifying validated actives, regulatory mapping, and connecting with manufacturing partners—significantly reducing decision latency. “Today, companies are fast-tracking their product cycles in ways that were unthinkable even two years ago,” he explains.
Looking ahead, NutrifyGenie’s capabilities are set to expand. “The next evolution is where we bring even more intelligence to the front end. NutrifyGenie will begin offering predictive formulation paths based on geography, demographic demand, and clinical substantiation. It is moving from an engine of acceleration to one of precision.”
Reflecting on the recently concluded SumFlex 2025 summit, Srivastava calls it a pivotal moment in India’s nutraceutical journey. “SumFlex was not designed to be a typical industry gathering. It was meant to serve as a turning point,” he states. Two developments from the summit stand out. “First, the Rural Economic Forum MoU creates a formal bridge between rural nutraceutical entrepreneurship and global value chains. That is a structural shift in how inclusivity can be embedded in high-growth sectors. Second, the launch of Rx.NutrifyToday.com. It signals to the medical community that we are serious about accountability, clinical relevance, and science-first nutrition.” According to Srivastava, these outcomes equip India with both scale and credibility to lead globally. At the core of Srivastava’s mission is a deep commitment to ethical innovation. “If this industry becomes driven solely by commercial opportunity, it risks losing trust. For us, ‘karma in action’ is a discipline,” he asserts.
He emphasizes that integrity is not a side note but central to the Nutrify Today model. “It is embedded in how we validate science, engage with micro-enterprises, and select which innovations to back. The economic model has to align with the long-term public good. Growth happens when you stay grounded in that, but it does not come at the cost of integrity.” Nutrify Today’s inclusivity initiatives go beyond rhetoric. “This work begins with recognising that innovation is not limited to city labs,” Srivastava notes, speaking about the organisation’s focus on rural and tier-2 institutional R&D. “Our job is to give those innovations a legitimate pathway into the global market. Project One Future and the MoU with the Rural Economic Forum allow us to formalise that process. We are not just aggregating micro-enterprises but enabling them to compete and scale in global wellness frameworks.” India’s role in the global nutraceutical arena is poised to expand, thanks to its unique assets. “India has a unique leverage right now. We sit at the intersection of scientific capability, biodiversity, and scalable manufacturing,” Srivastava explains.
This strategic position allows India to lead in regulatory harmonization and standard-setting. “We have already begun engaging with international forums to propose more cohesive, evidence-backed frameworks. The goal is leadership grounded in collaboration and responsibility.”
With more than 3.6 million curated data points, NutrifyGenie ensures that its insights are not just fast but credible. “A large volume of data is meaningless without context and transparency,” Srivastava stresses.
He elaborates on the platform’s integrity-focused structure: “Every data point, clinical trial output or toxicology input is referenced, tiered by credibility, and linked to compliance pathways. We also keep interfaces open for medical professionals and researchers to challenge or contribute, making it a dynamic validation loop. This is not a tool for speed alone. It is built to enable informed, accountable decisions.”
The launch of Rx.NutrifyToday.com has been a major step towards bridging the gap between clinical medicine and nutraceuticals. “Clinical adoption of nutraceuticals has been limited not due to lack of efficacy, but due to lack of trust and evidence standardisation,” says Srivastava.
The platform provides doctors with a reliable reference point. “It equips doctors with a reference environment that aligns with their training: objective data, risk-benefit analysis, toxicity profiles, and validated claims. We already see early signs of improved physician engagement and confidence in using nutraceutical interventions alongside primary treatment. That is the shift we want to institutionalise.”
Platforms like Dealsphere promise commercialization within just 15 days, but Srivastava assures that this speed doesn’t sacrifice quality. “Dealsphere’s speed comes from compression, not omission,” he clarifies. “We have digitised the licensing journey, matched it with validated manufacturing partners, and layered it with Nutrify Genie’s regulatory insights. What used to be a long chain of disconnected workflows is now a single continuum. No shortcuts are taken on compliance or safety. In fact, the system flags and halts any formulation that lacks scientific or regulatory backing. Acceleration only makes sense when it increases quality, not just velocity.”
With a 50% women workforce and a cross-disciplinary team, Nutrify Today embraces diversity as a strength. “Our products are meant to serve diverse populations. If the people building them don’t reflect that, we lose nuance, empathy, and insight,” Srivastava affirms.
He underscores that this inclusivity is intentional. “Having a gender-balanced team and cross-disciplinary input forces better questions, deeper discussions, and more resilient outcomes. This is a function of how we hire, who we mentor, and what we value. Innovation isn’t just technical but cultural. And diversity strengthens that culture.”
Looking to the future, Srivastava outlines the company’s mission to address growing global health issues. “The biggest challenge is the erosion of preventive health infrastructure. Whether it is metabolic disorders, micronutrient imbalances, or gut health, the problem is systemic and growing.”
Nutrify Today is proactively building the future of responsible nutrition. “Our goal is to make scientifically backed, accessible preventive nutrition a core part of healthcare and not an afterthought. We are actively pursuing collaborations with clinical research organisations, hospitals, and even insurance providers to get there. We are also investing in platforms that bring consumer data into formulation strategy so that we can design with clarity and scale with confidence.”
